(Q38134169)

29 August 2017

title

Involvement of free radicals and oxidative stress in NAFLD/NASH. (English)

1 reference

29 August 2017

Y Sumida

1

1 reference

29 August 2017

E Niki

series ordinal

2

1 reference

29 August 2017

Y Naito

series ordinal

3

1 reference

29 August 2017

T Yoshikawa

series ordinal

4

1 reference

29 August 2017

publication date

4 October 2013

1 reference

29 August 2017

published in

Free Radical Research

1 reference

29 August 2017

volume

47

1 reference

29 August 2017

issue

11

1 reference

29 August 2017

page(s)

869-880

1 reference

Nonalcoholic fatty liver disease and lipids

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Molecular mechanisms involved in NAFLD progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

The plasma lipidomic signature of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

The role of oxidative stress in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Mass-spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Free radical lipid peroxidation: mechanisms and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Lipid peroxidation: physiological levels and dual biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

The specificity of lipoxygenase-catalyzed lipid peroxidation and the effects of radical-scavenging antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Vitamin E and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Cytochrome p450 and chemical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Pathways of cholesterol oxidation via non-enzymatic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Cholesterol-metabolizing cytochromes P450

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Oxysterol biosynthetic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

The liver X receptor: a master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Alcohol, oxidative stress and free radical damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Oxidative stress, toxicology, and pharmacology of CYP2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Free-radical mechanisms in tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Bioactivation of carbon tetrachloride, chloroform and bromotrichloromethane: Role of cytochrome P-450

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Spin-trapping of the trichloromethyl radical produced during enzymic NADPH oxidation in the presence of carbon tetrachloride or bromotrichloromethane

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Free radical initiators as source of water- or lipid-soluble peroxyl radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Damage to biological tissues induced by radical initiator 2,2'-azobis(2-amidinopropane) dihydrochloride and its inhibition by chain-breaking antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Oxidation of lipids. XV. Role of hydrophilic diarylamines as antioxidants in the oxidations of lipids and biological tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Free radical-induced liver injury. II. Effects of intraperitoneally administered 2,2'-azobis(2-amidinopropane) dihydrochloride on the fatty acid profiles of hepatic triacylglycerol and phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Acceleration of lipid peroxidation in alpha-tocopherol transfer protein-knockout mice following the consumption of drinking water containing a radical initiator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Cholesterol, reactive oxygen species, and the formation of biologically active mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Effect of chronic ethanol feeding on oxysterols in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

CYP2E1 and oxidative liver injury by alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Effects of alpha-tocopherol on carbon tetrachloride metabolism in rat liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Effect of alpha-tocopherol on carbon tetrachloride intoxication in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Effects of tocotrienol on tumor necrosis factor-α/d-galactosamine-induced steatohepatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Tocopherylquinone and tocopherylhydroquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Assessment of antioxidant capacity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Regulatory mechanisms of cellular response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Discovery of the negative regulator of Nrf2, Keap1: a historical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Nrf2: a potential target for new therapeutics in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

Necrogenic Action of Carbon Tetrachloride in the Rat: A Speculative Mechanism Based on Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2013.837577

10.3109/10715762.2013.837577

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference